These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 8633046)

  • 1. Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers.
    Zlokovic BV; Martel CL; Matsubara E; McComb JG; Zheng G; McCluskey RT; Frangione B; Ghiso J
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4229-34. PubMed ID: 8633046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrovascular transport of Alzheimer's amyloid beta and apolipoproteins J and E: possible anti-amyloidogenic role of the blood-brain barrier.
    Zlokovic BV
    Life Sci; 1996; 59(18):1483-97. PubMed ID: 8890929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of apolipoprotein J-amyloid beta-peptide complex with low density lipoprotein receptor-related protein-2/megalin. A mechanism to prevent pathological accumulation of amyloid beta-peptide.
    Hammad SM; Ranganathan S; Loukinova E; Twal WO; Argraves WS
    J Biol Chem; 1997 Jul; 272(30):18644-9. PubMed ID: 9228033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycoprotein 330/megalin (LRP-2) has low prevalence as mRNA and protein in brain microvessels and choroid plexus.
    Chun JT; Wang L; Pasinetti GM; Finch CE; Zlokovic BV
    Exp Neurol; 1999 May; 157(1):194-201. PubMed ID: 10222122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of glycoprotein 330 as an endocytic receptor for apolipoprotein J/clusterin.
    Kounnas MZ; Loukinova EB; Stefansson S; Harmony JA; Brewer BH; Strickland DK; Argraves WS
    J Biol Chem; 1995 Jun; 270(22):13070-5. PubMed ID: 7768901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The putative blood-brain barrier transporter for the beta-amyloid binding protein apolipoprotein j is saturated at physiological concentrations.
    Shayo M; McLay RN; Kastin AJ; Banks WA
    Life Sci; 1997; 60(7):PL115-8. PubMed ID: 9042383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoform-specific effects of apolipoproteins E2, E3, and E4 on cerebral capillary sequestration and blood-brain barrier transport of circulating Alzheimer's amyloid beta.
    Martel CL; Mackic JB; Matsubara E; Governale S; Miguel C; Miao W; McComb JG; Frangione B; Ghiso J; Zlokovic BV
    J Neurochem; 1997 Nov; 69(5):1995-2004. PubMed ID: 9349544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of megalin/gp330 as a receptor for lipoprotein(a) in vitro.
    Niemeier A; Willnow T; Dieplinger H; Jacobsen C; Meyer N; Hilpert J; Beisiegel U
    Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):552-61. PubMed ID: 10073957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain uptake of circulating apolipoproteins J and E complexed to Alzheimer's amyloid beta.
    Zlokovic BV; Martel CL; Mackic JB; Matsubara E; Wisniewski T; McComb JG; Frangione B; Ghiso J
    Biochem Biophys Res Commun; 1994 Dec; 205(2):1431-7. PubMed ID: 7802679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein J and Alzheimer's amyloid beta solubility.
    Matsubara E; Soto C; Governale S; Frangione B; Ghiso J
    Biochem J; 1996 Jun; 316 ( Pt 2)(Pt 2):671-9. PubMed ID: 8687416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of Amyloid-β1-40 Transport by ApoA1 and ApoJ Across an in vitro Model of the Blood-Brain Barrier.
    Merino-Zamorano C; Fernández-de Retana S; Montañola A; Batlle A; Saint-Pol J; Mysiorek C; Gosselet F; Montaner J; Hernández-Guillamon M
    J Alzheimers Dis; 2016 May; 53(2):677-91. PubMed ID: 27232214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of apolipoprotein J-Alzheimer's A beta interaction.
    Matsubara E; Frangione B; Ghiso J
    J Biol Chem; 1995 Mar; 270(13):7563-7. PubMed ID: 7706304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional and structural properties of lipid-associated apolipoprotein J (clusterin).
    Calero M; Tokuda T; Rostagno A; Kumar A; Zlokovic B; Frangione B; Ghiso J
    Biochem J; 1999 Dec; 344 Pt 2(Pt 2):375-83. PubMed ID: 10567218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid beta binding proteins in vitro and in normal human cerebrospinal fluid.
    Golabek A; Marques MA; Lalowski M; Wisniewski T
    Neurosci Lett; 1995 May; 191(1-2):79-82. PubMed ID: 7659297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex.
    Ghiso J; Matsubara E; Koudinov A; Choi-Miura NH; Tomita M; Wisniewski T; Frangione B
    Biochem J; 1993 Jul; 293 ( Pt 1)(Pt 1):27-30. PubMed ID: 8328966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The choroid plexus removes beta-amyloid from brain cerebrospinal fluid.
    Crossgrove JS; Li GJ; Zheng W
    Exp Biol Med (Maywood); 2005 Nov; 230(10):771-6. PubMed ID: 16246905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein J (clusterin) and Alzheimer's disease.
    Calero M; Rostagno A; Matsubara E; Zlokovic B; Frangione B; Ghiso J
    Microsc Res Tech; 2000 Aug; 50(4):305-15. PubMed ID: 10936885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of apolipoprotein J-positive beta-amyloid plaques with dystrophic neurites in Alzheimer's disease brain.
    Martin-Rehrmann MD; Hoe HS; Capuani EM; Rebeck GW
    Neurotox Res; 2005; 7(3):231-42. PubMed ID: 15897157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that epithelial glycoprotein 330/megalin mediates uptake of polybasic drugs.
    Moestrup SK; Cui S; Vorum H; Bregengård C; Bjørn SE; Norris K; Gliemann J; Christensen EI
    J Clin Invest; 1995 Sep; 96(3):1404-13. PubMed ID: 7544804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory effects of simvastatin and apoJ on APP processing and amyloid-β clearance in blood-brain barrier endothelial cells.
    Zandl-Lang M; Fanaee-Danesh E; Sun Y; Albrecher NM; Gali CC; Čančar I; Kober A; Tam-Amersdorfer C; Stracke A; Storck SM; Saeed A; Stefulj J; Pietrzik CU; Wilson MR; Björkhem I; Panzenboeck U
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Jan; 1863(1):40-60. PubMed ID: 28941799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.